Retinitis Pigmentosa, Stem Cell Treatment for Retinitis Pigmentosa

The use of stem cells to treat Retinitis Pigmentosa (RP) has advanced dramatically in recent years. In order to optimise efficacy, this novel treatment entails implanting stem cells using efficient channels including retrobulbar injection. Modern facilities are now available at Eye stem cell center for the treatment of many eye disorders, including RP.

The symptoms of RP, a genetic eye disease that can cause blindness, include impaired night vision and progressive loss of peripheral vision, which frequently results in “tunnel vision.” Due to mutations in more than 50 genes, it is frequently inherited within families. The underlying cause of the disorder is the gradual deterioration of rod photoreceptor cells in the rear of the eye, which then affects cone cells that are in charge of central vision and color perception.

Retinitis pigmentosa Treatment in India

Retinitis pigmentosa is frequently inherited and typically passed on from a parent to their child, according to our medical specialists who treat patients with stem cell therapy in India. In certain instances, the illness may cause symptoms to become apparent during childhood, but in other circumstances, the eyes may be affected later in life. We provide more than simply stem cell therapy; we guarantee an accurate diagnosis of your illness.

Stem Cell Treatment for Retinitis Pigmentosa is the ultimate cure for you:

Stem cell treatment for Retinitis pigmentosa: using stem cells to replace damaged cells or tissues with repaired ones. The source of these stem cells might come from bone marrow transplants, blood transfusions directly into the bloodstream, or the patient’s own body for self-healing. By focusing on cancer cells, this stem cell therapy for retinal pigmentosa has also shown promise in treating a number of other illnesses, such as blood problems.

Patients undergoing some stem cell treatments for cancer may be administered high dosages of medicine, perhaps in conjunction with radiation therapy, in an effort to eliminate cancerous cells. After that, medical professionals inject the patient’s own healthy cells or healthy stem cells that were previously harvested from a donor back into the body. After migrating to the bone marrow, these recently added stem cells eventually produce new, healthy stem cells.

By infusing the body with healthy cells, stem cell therapy promotes healing and provides significant advantages to the patient.

 How Retinitis Pigmentosa Treated:

An investigational stem cell-based treatment for Retinitis Pigmentosa (RP) has shown a satisfactory safety profile in the ongoing Phase I/II clinical trial. The treatment aims to maintain and maybe improve eyesight in patients with RP treatment in india Being one of the first stem cell treatments for RP, this is a major turning point, and the safety data is very important. The Foundation in charge of this study expects more learnings and breakthroughs in the upcoming years as the experiment continues.

Retinitis pigmentosa is a disorder marked by progressive loss of vision that eventually results in blindness as people age. It includes a variety of hereditary illnesses that can be inherited from one or both parents. Leber’s congenital amaurosis (LCA), Usher syndrome, Rod-cone disease, and Bardet-Biedl syndrome are notable disorders linked to RP.